|
Dordick is the Howard P. Isermann Professor of Chemical and Biological Engineering and holds a joint appointment in the Department of Biology. He joined the Rensselaer faculty in 1998 and served as the Chemical and Biological Engineering Department chairman for four years. Dordick began his academic career at the University of Iowa as an assistant professor and eventually was promoted to full professor in 1994. He served as chairman of the Chemical and Biochemical Engineering Department from 1995-�98 and as associate director of the Center for Biocatalysis and Bioprocessing from 1991-�98. Dordick also held a joint position in the university's Division of Medicinal and Natural Products Chemistry in the College of Pharmacy.
The associate editor for Biotechnology & Bioengineering, Dordick also currently serves on the editorial boards of Enzyme and Microbial Technology, Biocatalysis and Biotransformation, Journal of Environmental Polymer Degradation, and Metabolic Engineering. He also has been a member of the editorial board of the Journal of Industrial Microbiology, was the patents and literature section editor for Applied Biochemistry and Biotechnology (1990-�93), and the associate editor of Biocatalysis and Biotransformation (1992-�95). He has published over 175 papers and holds 28 patents.
Among the prestigious awards Dordick has received include the 2003 International Enzyme Engineering Award, the 1998 American Chemical Society (ACS) Iowa Section Award, the National Science Foundation Presidential Young Investigator Award, and the Faculty Scholar Award from the University of Iowa. He received a NASA Technical Brief Citation in 1989 and was the Old Gold Summer Fellowship winner for the University of Iowa in 1988. Dordick also was elected a Fellow for the American Institute for Medical and Biological Engineering in 1996
Dordick has made numerous significant contributions to the field of biotechnology. He was the co-founder of EnzyMed, Inc., a pharmaceutical discovery company that was acquired by Albany Molecular in 1999. He is currently a co-founder of Solidus Biosciences, a venture-stage biotechnology company. In addition, he serves on the scientific advisory boards for several biotechnology companies. Dordick served as a past chair of the division of biochemical technology for the ACS. | 